These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37517604)

  • 21. Improved Prediction of Michaelis Constants in CYP450-Mediated Reactions by Resilient Back Propagation Algorithm.
    Dai H; Xu Q; Xiong Y; Liu WL; Wei DQ
    Curr Drug Metab; 2016; 17(7):673-80. PubMed ID: 27174458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updates on cytochrome P450-mediated cardiovascular drug interactions.
    Cheng JW; Frishman WH; Aronow WS
    Am J Ther; 2009; 16(2):155-63. PubMed ID: 19114873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo.
    Sychev DA; Ashraf GM; Svistunov AA; Maksimov ML; Tarasov VV; Chubarev VN; Otdelenov VA; Denisenko NP; Barreto GE; Aliev G
    Drug Des Devel Ther; 2018; 12():1147-1156. PubMed ID: 29780235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of cytochrome P450 inhibition assays for drug discovery using human liver microsomes with LC-MS, rhCYP450 isozymes with fluorescence, and double cocktail with LC-MS.
    Di L; Kerns EH; Li SQ; Carter GT
    Int J Pharm; 2007 Apr; 335(1-2):1-11. PubMed ID: 17137735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico prediction of drug metabolism by P450.
    Andrade CH; Silva DC; Braga RC
    Curr Drug Metab; 2014; 15(5):514-25. PubMed ID: 25204822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-cytochrome P450 enzymes involved in the oxidative metabolism of xenobiotics: Focus on the regulation of gene expression and enzyme activity.
    Pang X; Tang C; Guo R; Chen X
    Pharmacol Ther; 2022 May; 233():108020. PubMed ID: 34637840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery.
    Yan Z; Caldwell GW
    Curr Top Med Chem; 2001 Nov; 1(5):403-25. PubMed ID: 11899105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of CYP3A4 in vitro data to predict clinical drug-drug interactions; predictions of compounds as objects of interaction.
    Youdim KA; Zayed A; Dickins M; Phipps A; Griffiths M; Darekar A; Hyland R; Fahmi O; Hurst S; Plowchalk DR; Cook J; Guo F; Obach RS
    Br J Clin Pharmacol; 2008 May; 65(5):680-92. PubMed ID: 18279465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in silico Approaches to Study Cytochrome P450-Mediated Interactions.
    Tan BH; Pan Y; Dong AN; Ong CE
    J Pharm Pharm Sci; 2017; 20(1):319-328. PubMed ID: 29145931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYPlebrity: Machine learning models for the prediction of inhibitors of cytochrome P450 enzymes.
    Plonka W; Stork C; Šícho M; Kirchmair J
    Bioorg Med Chem; 2021 Sep; 46():116388. PubMed ID: 34488021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Review: Effects of Macrolides on CYP450 Enzymes.
    Zhang L; Xu X; Badawy S; Ihsan A; Liu Z; Xie C; Wang X; Tao Y
    Curr Drug Metab; 2020; 21(12):928-937. PubMed ID: 32807049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational Prediction of Inhibitors and Inducers of the Major Isoforms of Cytochrome P450.
    Rudik A; Dmitriev A; Lagunin A; Filimonov D; Poroikov V
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling and integrating interactions involving the CYP450 enzyme system in a multi-terminology server: Contribution to information extraction from a clinical data warehouse.
    Gosselin L; Letord C; Leguillon R; Soualmia LF; Dahamna B; Mouazer A; Disson F; Darmoni SJ; Grosjean J
    Int J Med Inform; 2023 Feb; 170():104976. PubMed ID: 36599261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs.
    Ohno Y; Hisaka A; Suzuki H
    Clin Pharmacokinet; 2007; 46(8):681-96. PubMed ID: 17655375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of cytochrome p450 induction: potential for drug-drug interactions.
    Jana S; Paliwal J
    Curr Protein Pept Sci; 2007 Dec; 8(6):619-28. PubMed ID: 18220847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine learning algorithms for the prediction of hERG and CYP450 binding in drug development.
    Klon AE
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):821-33. PubMed ID: 20465523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Human Cytochrome P450 Inhibition Using a Multitask Deep Autoencoder Neural Network.
    Li X; Xu Y; Lai L; Pei J
    Mol Pharm; 2018 Oct; 15(10):4336-4345. PubMed ID: 29775322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel application of 2D and 3D-similarity searches to identify substrates among cytochrome P450 2C9, 2D6, and 3A4.
    Freitas RF; Bauab RL; Montanari CA
    J Chem Inf Model; 2010 Jan; 50(1):97-109. PubMed ID: 20055489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats.
    Wang B; Yang S; Hu J; Li Y
    J Ethnopharmacol; 2014 Sep; 155(3):1473-82. PubMed ID: 25091466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches.
    Magliocco G; Thomas A; Desmeules J; Daali Y
    Clin Pharmacokinet; 2019 Nov; 58(11):1373-1391. PubMed ID: 31131437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.